A Randomized Double-blinded Trial to Explore the Optimum Dose of Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery

Trial Profile

A Randomized Double-blinded Trial to Explore the Optimum Dose of Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2016

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Postoperative haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
    • 29 Jul 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Aug 2014, as per ClinicalTrials.gov record.
    • 06 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top